Peritoneal mononuclear cell differentiation and cytokine production in intermittent and continuous automated peritoneal dialysis

American Journal of Kidney Diseases

Volumn 31, Issue 2, 1998, Pages 234-241

  Wrenger, Eike ^a   Baumann, Carsten ^b   Behrend, Matthias ^b   Zamore, Enrico ^b   Schindler, Ralf ^b   Brunkhorst, Reinhard ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NONE

Author keywords

Cell differentiation; Continuous cyclic peritoneal dialysis; Cytokines; Nightly intermittent peritoneal dialysis

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL REGENERATION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MALE; PERITONEUM MACROPHAGE;

EID: 0031906856     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9469493     Document Type: Article

References (55)

1. Lupo A, Tarchini R, Carcarini G, Catizone L, Cocchi R, De Vecchi A, Viglino G, Salomone M, Segoloni G, Giangrande A: Long-term outcome in continuous ambulatory peritoneal dialysis: A 10-year survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis 24:826-837, 1994
2. Suassuna JH, Das Neves FC, Hartley RB, Ogg CS, Cameron JS: Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 46:443-454, 1994
3. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hoefsmit EC, Beelen RH: Immuno-effector characteristics of peritoneal cells during CAPD treatment: A longitudinal study. Kidney Int 43:641-648, 1993
4. Keane WF, Comty CM, Verbrugh HA, Peterson PK: Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 25:539-543, 1984
5. Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD: Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 26:733-740, 1984
6. Lewis SL, Norris PJ, Holmes CJ: Phenotypic characterization of monocytes and macrophages from CAPD patients. ASAIO Trans 36:M575-577, 1990
7. McGregor SJ, Brock JH, Briggs JD, Junor BJ: Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis. Nephrol Dial Transplant 2:551-556, 1987
8. Peterson PK, Gaziano E, Suh HJ, Devalon M, Peterson L, Keane WF: Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun 49:212-218, 1985
9. Verbrugh HA, Keane WF, Hoidal JR, Freiberg MR, Elliott GR, Petersen PK: Peritoneal macrophages and opsonins: Antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 147:1018-1029, 1983
10. Mackenzie RK, Coles GA, Williams JD: The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis. J Infect Dis 163:837-842, 1991
11. Vanholder R, Lameire N, Waterloos MA, Van Landschool N, De Smet R, Vogeleere P, Lambert MC, Vijt D, Ringoir S: Disturbed host defense in peritoneal cavity during CAPD: Characterization of responsible factors in dwell fluid. Kidney Int 50:643-652, 1996
12. Topley N, Williams JD: Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46:71-78, 1994
13. Bos HJ, van Bronswijk H, Helmerhorst TJ, Oe PL, Hoefsmit EC, Beelen RH: Distinct subpopulations of elicited human macrophages in peritoneal dialysis patients and women undergoing laparoscopy: A study on peroxidatic activity. J Leukoc Biol 43:172-178, 1988
14. Bos HJ, Meyer F, de Veld JC, Beelen RH: Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions. Kidney Int 36:20-26, 1989
15. McGregor SJ, Brock JH, Briggs JD, Junor BJ: Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls. Clin Immunol Immunopathol 56:151-158, 1990
16. Moughal NA, McGregor SJ, Brock JH, Briggs JD, Junor BJ: Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD). Eur J Clin Invest 21:592-596, 1991
17. Bos HJ, Vlaanderen K, Van der Meulen J, De Veld J, Oe LP, Beelen RHJ: Peritoneal macrophages in short dwell time effluent show diminished phagocytosis. Perit Dial Int 8:199-202, 1988
18. Alobaidi HM, Coles GA, Davies M, Lloyd D: Host defence in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1:16-21, 1986
19. de Fijter CW, Verbrugh HA, Oe LP, Heezius E, Donker AJ, Verhoef J, Gokal R: Biocompatibility of a glucose-polymer - containing peritoneal dialysis fluid. Am J Kidney Dis 21:411-418, 1993
20. de Fijter CWH, Verbrugh HA, Peters EDJ, Oe PL, van der Meulen J, Verhoef J, Donker AJM: In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 39:75-80, 1993
21. Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D: The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34:404-411, 1988
22. Jorres A, Jorres D, Gahl GM, Kessel M, Muller C, Kottgen E, Serke S, Schulz E, Mahiout A: Leukotriene B4 and tumor necrosis factor release from leukocytes: Effect of peritoneal dialysate. Nephron 58:276-282, 1991
23. Jorres A, Topley N, Steenweg L, Muller C, Kottgen E, Gahl GM: Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 12:80-85, 1992
24. Steinhauer HB, Brugger U, Atmanspacher R, Lubrich-Birkner I, Schollmeyer P: Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages. Adv Perit Dial 8:47-52, 1992
25. de Fijter CWH, Verbrugh HA, Oe LP, Peters ED, van dMJ, Donker AJ, Verhoef J: Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 42:947-950, 1992
26. Mahiout A, Brunkhorst R: Pyruvate anions neutralize peritoneal dialysate cytotoxicity. Nephrol Dial Transplant 10:391-394, 1995
27. Zwadlo G, Schlegel R, Sorg C: A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 137:512-518, 1986
28. Zwadlo G, Brocker EB, von Bassewitz DB, Feige U, Sorg C: A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 134:1487-1492, 1985
29. Zwadlo G, Voegeli R, Osthoff KS, Sorg C: A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 55:295-304, 1987
30. van der Meer JWM, Endres S, Lonnemann G, Cannon JG, Ikejima T, Okusawa S, Gelfand JA, Dinarello CA: Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol 43:216-223, 1988
31. Endres S, Ghorbani R, Lonnemann G, van der Meer JWM, Dinarello CA: Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: Optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol 49:424-438, 1988
32. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA: Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47, 1990
33. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA: Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 78:1275-1281, 1991
34. Brunkhorst R, Wrenger E, Krautzig S, Ehlerding G, Mahiout A, Koch KM: Clinical experience with home automated peritoneal dialysis. Kidney Int 46:25-30, 1994 (suppl 48)
35. Vlaanderen K, Bos HJ, de Fijter CW, Oe LP, van der Meulen J, Verbrugh HA, Beelen RH: Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients. Nephron 57:29-35, 1991
36. Verbrugh HA, Keane WF, Conroy WE, Peterson PK: Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids. J Clin Microbiol 20:199-203, 1984
37. Bennett-Jones DN, Yewdall VM, Gillespie CM, Ogg CS, Cameron JS: Strain differences in the opsonisation of Staphylococcus epidermidis. Perit Dial Int 9:333-339, 1989
38. Brüggen J, Tarcsay L, Cerletti N, Odink K, Rutishauser M, Holländer G, Sorg C: The molecular nature of the cystic fibrosis antigen. Nature 331:570-573, 1988
39. Mahnke K, Bhardwaj R, Sorg C: Heterodimers of the calcium-binding proteins MRP8 and MRP14 are expressed on the surface of human monocytes upon adherence to fibronectin and collagen. Relation to TNF-alpha, IL-6, and superoxide production. J Leukoc Biol 57:63-71, 1995
40. Goebeler M, Roth J, Burwinkel F, Vollmer E, Bocker W, Sorg C: Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. Transplantation 58:355-361, 1994
41. Roth J, Goebeler M, Wrocklage V, van den Bos C, Sorg C: Expression of the calcium-binding proteins MRP8 and MRP14 in monocytes is regulated by a calcium-induced suppressor mechanism. Biochem J 301:655-660, 1994
42. Schmid KW, Lugering N, Stoll R, Brinkbaumer P, Winde G, Domschke W, Bocker W, Sorg C: Immunohistochemical demonstration of the calcium-binding proteins MRP8 and MRP14 and their heterodimer (27E10 antigen) in Crohn's disease. Hum Pathol 26:334-337, 1995
43. Striz I, Wang YM, Teschler H, Sorg C, Costabel U: Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis. Lung 171:293-303, 1993
44. Douvdevani A, Rapoport J, Konforti A, Zlotnik M, Chaimovitz C: The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF alpha by macrophages/ monocytes. Perit Dial Int 13:112-117, 1993
45. Lin CY, Ku WL, Huang TP: Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Am J Nephrol 10:368-373, 1990
46. Hart PH, Jones CA, Jones KL, Finlay-Jones JJ: Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis. Immunol Cell Biol 71:99-107, 1993
47. Duwe AK, Vas SI, Weatherhead JW: Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 33:130-135, 1981
48. Brunkhorst R, Mahiout A: Pyruvate neutralizes peritoneal dialysate cytotoxicity: Maintained integrity and proliferation of cultured human mesothelial cells. Kidney Int 48:177-181, 1995
49. Pedersen FB, Ryttov N, Deleuran P, Dragsholt C, Kildeberg P: Acetate versus lactate in peritoneal dialysis solutions. Nephron 39:55-58, 1985
50. Dinarello CA, Thompson RC: Blocking IL-1: Interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 12:404-410, 1991
51. Arend WP, Welgus HP, Thompson RC, Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonists. J Clin Invest 85:1694-1697, 1990
52. Descamps-Latscha B, Herbelin A, Nguyen AT, RouxLombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P, et al: Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892, 1995
53. Moutabarrik A, Nakanishi I, Namiki M, Tsubakihara Y: Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Clin Nephrol 43:243-248, 1995
54. de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, Donker AJ: Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 120:264-271, 1994
55. McGregor SJ, Topley N, Jörres A, Speekenbrink ABJ, Gordon A, Gahl GM, Junor BJR, Briggs JD, Brock JH: Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: Maturity, cytokine synthesis and arachidonic acid metabolism. Kidney Int 49:525-533, 1996